Results Healthcare has advised UCB on the divestment of its nitrate products in Europe and other selected markets to Merus Labs

  • Service: Divestments
  • Sector: Healthcare
  • Sub Sector: Pharma & Biotech
  • Engagement Type: Sell Side
Feb 2016
has divested nitrate product rights in selected markets to

The Total Healthcare Group – founded in 1996 by Dr Robert Hollamby – is a specialist global value research consultancy comprising Total Healthcare Solutions and Total Healthcare Media. The pricing and reimbursement capabilities of the group are underpinned by an unrivalled network of payer contacts covering over 40 markets, along with a track record of more than 800 consultancy projects and 90 Global Value Dossiers across all major therapy areas.

THG is one of only a handful of truly international Pricing and Reimbursement and Payer Research Consultancies in the world. It was essential to find an acquirer to help THG develop a more substantial footprint in the US, and provide the resources and infrastructure to support THG’s growth plan, whilst remaining sympathetic to THG’s DNA and staff aspirations.

Results International were selected as Corporate Finance advisor to THG after a 6 way selection process. Results International ran a competitive process securing offers from an impressive group of international healthcare consultancies, research and private equity businesses.

Q: Why did you choose Results International?

A previous attempt to sell the business did not succeed, in part due to the advisor’s unimpressive performance; as such we were well informed about what was required this time. Results International clearly had a good grasp of our sector and the specific issues of a professional services business. They demonstrated a genuine interest in our business and it was clear there was depth in their team with further reassurance that our project would include senior level input at all times.

Q: Did Results International live up to your expectations throughout the transaction?

Yes definitely. They remained totally committed throughout a difficult and protracted process with no sense of being distracted by other projects or, more importantly, going for the quick win opportunity.

Q: Where did Results International add value in the sale process?

At all stages. They identified good partners, conducted a very professional process, remained patient and negotiated well, were persistent at all times and on all material points, provided support in the due diligence process, were good counsel, kept me sane and gained not only our trust but also I believe the respect of UBC.

Q: Would you use Results International again?

Most definitely – though hopefully won’t have to! Having had an advisor who is only good at selling themselves, it’s great to have one that can actually sell someone else’s business. It’s all in the name!

This transformational acquisition is a major step forward in our strategy to acquire important established medicines and leverage our scalable commercial platform.

Barry Fishman

CEO, Merus Labs

Sector Related Deals

May 2021
has formed a strategic alliance with
Mar 2021
has licensed the patents and know-how to its Crystalomics Formulation Technology to
Jan 2021
has divested its Mirabel manufacturing site in Riom, France to
Jan 2021
has divested its Ringaskiddy analytics and testing site to
Oct 2020
has divested its Poznań, Poland manufacturing site to
Sep 2020
has divested its Barcelona manufacturing sites to
Sep 2020
has divested its Segré, France manufacturing facility to
May 2020
has acquired
Mar 2020
has divested its Mississauga, Ontario manufacturing facility to